Clinical trial No longer in our active list Interventional Ages 65 to 75

Improving upper body strength in elderly through blood flow restriction training

Official title: The Effect of Blood Flow Restrictive Exercise on Grip Strength and Upper Extremity Functions in Elderly Individuals

Run by Istanbul Medipol University Hospital · NCT05803733 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if a special training method that restricts blood flow can help older adults strengthen their upper body and improve their daily activities.

Quick facts

Study typeInterventional
Ages65 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorIstanbul Medipol University Hospital
Academic / other
Locations1 site (Istanbul, Beykoz)
Trial IDNCT05803733 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are elderly individuals aged 65 and over who are looking to improve their upper body strength and function.

Probably not a fit

Patients with recent upper extremity injuries, certain health conditions, or those who have recently engaged in upper extremity weight training may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on enhancing upper extremity strength and performance in elderly individuals by utilizing blood flow restriction training (BFRT) over a period of six weeks. The intervention aims to counteract the natural decline in muscle strength and function associated with aging, which can lead to decreased independence and increased risk of disability. Participants aged 65 and older will engage in low-load resistance training combined with BFRT, while those with certain health conditions or recent upper extremity training will be excluded. The study seeks to assess improvements in handgrip strength and overall upper body function as key indicators of enhanced independence.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life and independence of elderly patients by enhancing their upper body strength.

How similar studies have gone: Previous studies have shown promising results with blood flow restriction training in various populations, suggesting potential for success in this novel application for the elderly.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants aged 65 and over who are classified as advanced age according to the World Health Organization
* Volunteer basis

Exclusion Criteria:

* History of acute trauma to the hand or wrist
* Scrapped upper extremity
* Patients with symptoms of shoulder or elbow pain and rheumatoid arthritis,
* Those who have participated in upper extremity weight training training in the last 6 months,
* Those taking sedatives
* Upper extremity venous thrombosis,
* Being at high risk for cardiovascular conditions that interfere with exercise, unexplained chest pain or heart disease, fainting or dizziness during physical activity/exercise

Where it's running

  • Gizem Ergezen
    Istanbul, Beykoz, Turkey
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.